| Literature DB >> 19659435 |
Andrew P Levy1, Rabea Asleh, Shany Blum, Nina S Levy, Rachel Miller-Lotan, Shiri Kalet-Litman, Yefim Anbinder, Orit Lache, Farid M Nakhoul, Roy Asaf, Dan Farbstein, Mordechai Pollak, Yitzhak Z Soloveichik, Merav Strauss, Jonia Alshiek, Alina Livshits, Avery Schwartz, Hoda Awad, Kheir Jad, Hagit Goldenstein.
Abstract
Haptoglobin is an abundant hemoglobin-binding protein present in the plasma. The function of haptoglobin is primarily to determine the fate of hemoglobin released from red blood cells after either intravascular or extravascular hemolysis. There are two common alleles at the Hp genetic locus denoted 1 and 2. There are functional differences between the Hp 1 and Hp 2 protein products in protecting against hemoglobin-driven oxidative stress that appear to have important clinical significance. In particular, individuals with the Hp 2-2 genotype and diabetes mellitus appear to be at significantly higher risk of microvascular and macrovascular complications. A pharmacogenomic strategy of administering high dose antioxidants specifically to Hp 2-2 DM individuals may be clinically effective.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19659435 DOI: 10.1089/ars.2009.2793
Source DB: PubMed Journal: Antioxid Redox Signal ISSN: 1523-0864 Impact factor: 8.401